Shah Pharmacy Limited - Accounts to registrar (filleted) - small 18.2

Shah Pharmacy Limited - Accounts to registrar (filleted) - small 18.2


IRIS Accounts Production v18.3.0.592 07843615 Board of Directors Board of Directors 1.7.17 30.6.18 30.6.18 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure078436152017-06-30078436152018-06-30078436152017-07-012018-06-30078436152016-06-30078436152016-07-012017-06-30078436152017-06-3007843615ns15:EnglandWales2017-07-012018-06-3007843615ns14:PoundSterling2017-07-012018-06-3007843615ns10:Director12017-07-012018-06-3007843615ns10:Director22017-07-012018-06-3007843615ns10:PrivateLimitedCompanyLtd2017-07-012018-06-3007843615ns10:SmallEntities2017-07-012018-06-3007843615ns10:AuditExemptWithAccountantsReport2017-07-012018-06-3007843615ns10:SmallCompaniesRegimeForDirectorsReport2017-07-012018-06-3007843615ns10:SmallCompaniesRegimeForAccounts2017-07-012018-06-3007843615ns10:FullAccounts2017-07-012018-06-300784361512017-07-012018-06-3007843615ns10:RegisteredOffice2017-07-012018-06-3007843615ns5:CurrentFinancialInstruments2018-06-3007843615ns5:CurrentFinancialInstruments2017-06-3007843615ns5:ShareCapital2018-06-3007843615ns5:ShareCapital2017-06-3007843615ns5:RetainedEarningsAccumulatedLosses2018-06-3007843615ns5:RetainedEarningsAccumulatedLosses2017-06-3007843615ns5:NetGoodwill2017-07-012018-06-3007843615ns5:IntangibleAssetsOtherThanGoodwill2017-07-012018-06-3007843615ns5:FurnitureFittings2017-07-012018-06-3007843615ns5:NetGoodwill2017-06-3007843615ns5:NetGoodwill2018-06-3007843615ns5:NetGoodwill2017-06-3007843615ns5:FurnitureFittings2017-06-3007843615ns5:FurnitureFittings2018-06-3007843615ns5:FurnitureFittings2017-06-3007843615ns5:CurrentFinancialInstrumentsns5:WithinOneYear2018-06-3007843615ns5:CurrentFinancialInstrumentsns5:WithinOneYear2017-06-3007843615ns5:DeferredTaxation2017-06-3007843615ns5:DeferredTaxation2018-06-30


REGISTERED NUMBER: 07843615 (England and Wales)















FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 JUNE 2018

FOR

SHAH PHARMACY LIMITED

SHAH PHARMACY LIMITED (REGISTERED NUMBER: 07843615)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2018










Page

Company Information 1

Chartered Accountants' Report 2

Balance Sheet 3

Notes to the Financial Statements 5


SHAH PHARMACY LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 30 JUNE 2018







DIRECTORS: A V Shah
Mrs V A Shah





REGISTERED OFFICE: 13 North Parade
Southall
Middlesex
UB1 2LF





REGISTERED NUMBER: 07843615 (England and Wales)





ACCOUNTANTS: Sterling
Chartered Accountants
505 Pinner Road
Harrow
Middlesex
HA2 6EH

CHARTERED ACCOUNTANTS' REPORT TO THE BOARD OF DIRECTORS
ON THE UNAUDITED FINANCIAL STATEMENTS OF
SHAH PHARMACY LIMITED


The following reproduces the text of the report prepared for the directors in respect of the company's annual
unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file
a Balance Sheet. Readers are cautioned that the Statement of Comprehensive Income and certain other primary
statements and the Report of the Directors are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the
financial statements of Shah Pharmacy Limited for the year ended 30 June 2018 which comprise the Statement of
Comprehensive Income, Balance Sheet, Statement of Changes in Equity and the related notes from the company's
accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance.

This report is made solely to the Board of Directors of Shah Pharmacy Limited, as a body, in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Shah Pharmacy Limited and state those matters that we have agreed to state to the Board of Directors of Shah Pharmacy Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Shah Pharmacy Limited and its Board of Directors, as a body, for our work or for this report.

It is your duty to ensure that Shah Pharmacy Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Shah Pharmacy Limited. You consider that Shah Pharmacy Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Shah Pharmacy Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.






Sterling
Chartered Accountants
505 Pinner Road
Harrow
Middlesex
HA2 6EH


11 January 2019

SHAH PHARMACY LIMITED (REGISTERED NUMBER: 07843615)

BALANCE SHEET
30 JUNE 2018

30/6/18 30/6/17
Notes £ £ £ £
FIXED ASSETS
Intangible assets 4 437,500 468,750
Tangible assets 5 12,106 16,141
449,606 484,891

CURRENT ASSETS
Stocks 6 45,124 44,566
Debtors 7 72,024 65,980
Cash at bank and in hand 50,946 100,025
168,094 210,571
CREDITORS
Amounts falling due within one year 8 280,133 381,844
NET CURRENT LIABILITIES (112,039 ) (171,273 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

337,567

313,618

PROVISIONS FOR LIABILITIES 9 2,111 2,813
NET ASSETS 335,456 310,805

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 335,356 310,705
SHAREHOLDERS' FUNDS 335,456 310,805

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 June 2018.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 June 2018 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies
Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial
statements, so far as applicable to the company.

SHAH PHARMACY LIMITED (REGISTERED NUMBER: 07843615)

BALANCE SHEET - continued
30 JUNE 2018


The financial statements have been prepared and delivered in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

In accordance with Section 444 of the Companies Act 2006, the Statement of Comprehensive Income has not been delivered.

The financial statements were approved by the Board of Directors on 11 January 2019 and were signed on its behalf by:




A V Shah - Director



Mrs V A Shah - Director


SHAH PHARMACY LIMITED (REGISTERED NUMBER: 07843615)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2018


1. STATUTORY INFORMATION

Shah Pharmacy Limited is a private company, limited by shares , registered in England and Wales. The
company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of Section 1A "Small Entities" of Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover represents NHS prescription income and counter sales, excluding Value Added Tax.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2012, is being amortised evenly over its estimated useful life of twenty years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost
less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 25% on reducing balance

Stocks
Stocks are measured at the lower of cost and selling price less cost to sell. Cost is calculated on a first in, first out
basis and includes all costs of purchase, costs of conversion and other costs incurred in bringing the inventories
to their present location and condition.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to
the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or
substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance
sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from
those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that
have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the
timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they
will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

SHAH PHARMACY LIMITED (REGISTERED NUMBER: 07843615)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 JUNE 2018


3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 4 (2017 - 3 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£
COST
At 1 July 2017
and 30 June 2018 625,000
AMORTISATION
At 1 July 2017 156,250
Amortisation for year 31,250
At 30 June 2018 187,500
NET BOOK VALUE
At 30 June 2018 437,500
At 30 June 2017 468,750

5. TANGIBLE FIXED ASSETS
Fixtures
and
fittings
£
COST
At 1 July 2017
and 30 June 2018 26,711
DEPRECIATION
At 1 July 2017 10,570
Charge for year 4,035
At 30 June 2018 14,605
NET BOOK VALUE
At 30 June 2018 12,106
At 30 June 2017 16,141

6. STOCKS
30/6/18 30/6/17
£ £
Stocks 45,124 44,566

SHAH PHARMACY LIMITED (REGISTERED NUMBER: 07843615)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 JUNE 2018


7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30/6/18 30/6/17
£ £
Trade debtors 64,773 57,415
VAT 7,251 8,565
72,024 65,980

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30/6/18 30/6/17
£ £
Trade creditors 105,226 90,288
Tax 20,850 29,957
Social security and other taxes 2,648 1,450
Wages control 5,258 3,964
Directors' current accounts 28,351 73,015
Directors' loan accounts 114,325 180,000
Accrued expenses 3,475 3,170
280,133 381,844

9. PROVISIONS FOR LIABILITIES
30/6/18 30/6/17
£ £
Deferred tax 2,111 2,813

Deferred tax
£
Balance at 1 July 2017 2,813
movement during the year (702 )
Balance at 30 June 2018 2,111

10. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

During the year company made dividend payment of £30,000 (2017 £30,000) to the shareholders.

Included in creditors amounts following due after more than one year is a balance of £114,325 (2017 : £180,000)
for Mr A Shah, a director of the company.

11. ULTIMATE CONTROLLING PARTY

The company is jointly controlled by the directors, who also own 100% of the issued share capital.